 |
Poloxamer 188 |
|---|---|
| Trade Name | |
| Orphan Indication | Vasospasm in subarachnoid hemorrhage patients following surgical repair of a ruptured cerebral aneurysm |
| USA Market Approval | USA |
| USA Designation Date | 1997-08-05 00:00:00 |
| Sponsor | CytRx Corporation;154 Technology Parkway;Norcross, Georgia, 30092 |
